The Significance of Biological Risk Assessment (BRA) in Biocompatibility Testing

Biocompatibility testing stands as a cornerstone in ensuring the safety and efficacy of medical devices. Within this multifaceted testing landscape, the Biological Risk Assessment (BRA, also: BER – Biological Evaluation Report) emerges as a crucial tool for evaluating potential risks associated with the interaction of biological systems with medical devices. This article delves into the significance of BRA in biocompatibility testing, outlines its key components, and identifies the individuals best suited to undertake the task of crafting a comprehensive BRA.

Understanding MTT in Cytotoxicity Testing for Biocompatibility Assessment of Medical Devices

Biocompatibility testing plays a crucial role in ensuring the safety and efficacy of medical devices. Among the various tests employed, MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide) assay has emerged as a valuable tool in assessing cytotoxicity. This article delves into the significance of MTT in biocompatibility testing and provides insights into when and why this test is essential for medical devices.

What GLP Certification means in Medical Device Testing

In the ever-evolving landscape of medical device testing, the importance of adhering to rigorous standards cannot be overstated. Good Laboratory Practice (GLP) certification stands as a cornerstone, ensuring the reliability and integrity of testing processes. This article delves into the pivotal question: Why does GLP certification matter for medical device testing?

The Crucial Role of Biological Evaluation Plan (BEP) in Biocompatibility Testing

Biocompatibility testing stands at the forefront of ensuring the safety and efficacy of medical devices intended for use within the human body. With the ever-evolving landscape of medical technology, the need for robust testing methodologies becomes increasingly imperative. One such methodology is the Biological Evaluation Plan (BEP), a comprehensive framework that guides researchers through the process of assessing the biological safety of medical devices. In this article, we delve into the intricacies of BEP, exploring its significance in biocompatibility testing, its essential components, and its pivotal role in ensuring patient safety and regulatory compliance.

EO & ECH Residual Test

Ethylene oxide gas (EO) is a flammable and colorless gas commonly used in medical device sterilization. Its permitted maximum residual levels are set by a range of international and local organizations, including the International Organization for Standardization (i.e., ISO 10993-7:2008) and Japanese Industrial Standards (i.e., JIS T 0993-7:2012).

EO- & ECH-Rückstandstest

Ethylenoxidgas (EO) ist ein entflammbares und farbloses Gas, das häufig bei der Sterilisation von Medizinprodukten verwendet wird. Die zulässigen maximalen Restkonzentrationen werden von einer Reihe internationaler und lokaler Organisationen festgelegt, darunter die Internationale Organisation für Normung (z. B. ISO 10993-7:2008) und die japanischen Industrienormen (z. B. JIS T 0993-7:2012).

Hemocompatibilty

Hemolysis (direct & indirect)CoagulationPlatelet ActivationComplement ActivationHematology

BIOKOMPATIBILITÄT – WARUM, WANN und WIE?

Das Konzept der Biokompatibilität bezieht sich auf die Wechselwirkung zwischen den Geweben und den physiologischen Systemen eines Patienten, der mit einem Medizinprodukt behandelt wird. Die Bewertung der Biokompatibilität ist Teil der Gesamtbewertung der Produktsicherheit.